Scott Ackler
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
-
- Chronic Lymphocytic Leukemia Research
Papers in ⓘ
- Co-authors
- Saul H. Rosenberg (5 shared papers)Steven W. Elmore (5 shared papers)Anatol Oleksijew (6 shared papers)Michael J. Mitten (5 shared papers)David J. Frost (5 shared papers)Kelly Foster (5 shared papers)Marion Refici (3 shared papers)Stephen W. Fesik (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Oncogene (2 papers)Clinical Cancer Research (1 paper)Pharmacology Research & Perspectives (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Scott Ackler
10 papers receiving 613 citations
Peers
Comparison fields: 5 of 63
- Oncology 233
- Genetics 76
- Molecular Biology 472
- Pathology and Forensic Medicine 94
- Immunology 75
Countries citing papers authored by Scott Ackler
This map shows the geographic impact of Scott Ackler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Ackler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Ackler more than expected).
Fields of papers citing papers by Scott Ackler
This network shows the impact of papers produced by Scott Ackler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Ackler. The network helps show where Scott Ackler may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Ackler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 155 | |
| 2 | 2011 | 119 | |
| 3 | 2010 | 100 | |
| 4 | 2002 | 78 | |
| 5 | 2008 | 64 | |
| 6 | 2010 | 50 | |
| 7 | 2012 | 33 | |
| 8 | 2015 | 21 | |
| 9 | 2002 | 3 | |
| 10 | 2006 | 2 |
About Scott Ackler
Scott Ackler is a scholar working on Genetics, Oncology, Biophysics, Molecular Biology and Pathology and Forensic Medicine, having authored 10 papers that have together received 625 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer therapeutics and mechanisms (3 papers), Cell death mechanisms and regulation (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer-related gene regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (233 citations), Genetics (76 citations), Molecular Biology (472 citations), Pathology and Forensic Medicine (94 citations) and Immunology (75 citations). Scott Ackler has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Saul H. Rosenberg, Steven W. Elmore, Anatol Oleksijew, Michael J. Mitten, David J. Frost, Kelly Foster, Marion Refici, Stephen W. Fesik, Christin Tse and Michael D. Johnson. Their work appears in journals such as Molecular Cancer Therapeutics, Oncogene, Clinical Cancer Research, Pharmacology Research & Perspectives and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.